Liver Bridging Techniques in the Treatment of Acute Liver Failure

REFERENCES

• Adam R, Castaing D, Bismuth H. Transplantation of small donor livers in adult recipients. Transplant Proc. 1993;25:1105 –6.
   Google Scholar
• Arkadopoulo s N, Lilja H, Suh KS, Demetriou AA, Rozga J. Intrasplenic transplantation of allogenei c hep- atocytes prolongs survival in anhepatic rats. Hepatology. 1998;28:1365 –70.
   Google Scholar
• Arnaout WS, Moscioni AD, Barbour RL, Demetriou AA. Development of bioartifcial liver: bilirubin conjugation in Gunn rats. J Surg Res. 1990;48:379 –82.
   Google Scholar
• Ascher NL, Lake JR, Emond JC, Roberts JP. Liver trans- plantation for fulminant hepatic failure. Arch Surg. 1993;128:677–82. Ascher NL. Hepatocyte transplantation. Liver Transpl Surg. 1995;1:139–42.
   Google Scholar
• Bader A, Fruhauf N, Zech K, Haverich A, Borlak JT: Devel- opment of a small-scale bioreactor for drug metabolism studies maintaining hepatospecifc functions. Xenobiot- ica. 1998 Sep;28(9):815–25.
   PubMed Web of Science ®Google Scholar
• Bader A, Knop E, Fruhauf N, Crome O, Boker K, Christians U, Oldhafer K, Ringe B, Pichlmayr R, Sewing KF: Recon- struction of liver tissue in vitro: geometry of characteris- tic flat bed, hollow fber, and spouted bed bioreactors with reference to the in vivo liver. Artif Organs. 1995 Sep;19(9):941–50.
   PubMed Web of Science ®Google Scholar
• Bilir BM, Guenette D, Ostrowska A et al. Percutaneous hepatocyte transplantation (PHT) in liver failure. Hepatol- ogy. 1997;26:A252.
   Web of Science ®Google Scholar
• Bismuth H, Azoulay D, Samuel D, Reynes M, Grimon G, Majno P, Castaing D. Auxiliary partial orthotopic liver transplantation for fulminant hepatic failure. The Paul Brousse Experience. Ann Surg. 1996;224:712 –726.
   Google Scholar
• Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis. 1996;16:415–25.
   PubMed Web of Science ®Google Scholar
• Burnell JM, Runge C, Saunders FC, Thomas ED, Volwiler W. Acute hepatic failure treated by cross circulation. Arch Intern Med. 1973;132:493–8.
   PubMed Web of Science ®Google Scholar
• Chen SC, Hewitt WR, Watanabe FD, Eguchi S, Kahaku E, Middleton Y, Rozga J, Demetriou AA. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs. 1996;19:664 –9.
   Google Scholar
• 12. Chenard-Neu MP et al. Auxiliary liver transplantation: re- generation of the native liver and outcome in 30 patients with fulminant hepatic failure–a multicenter European study. Hepatology. 1996;23:1119 –27.
   Google Scholar
• Darby H, Gupta S, Johnstone R, Selden C, Hodgson HJ. Observations on rat spleen reticulum during the devel- opment of syngeneic hepatocellular implants. Br J Exp Pathol. 1986;67:329 –39.
   Google Scholar
• Dowling DJ, Mutimer DJ. Artifcial liver support in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:991 –6.
   Google Scholar
• Ebata H, Oikawa I, Mito M. Rejection of allogenei c hepa- tocytes and fetal hepatic tissue transplanted into the rat spleen. Transplantation. 1985;39:221 –3.
   Google Scholar
• Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg. 1965;162:329 –45.
   Google Scholar
• Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R. Pilot- controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996;24:1446 –51.
   Google Scholar
• Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older re- cipients. Ann Surg. 1996;224:544 –54.
   Google Scholar
• Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, Bismuth A, Castaing D, Bismuth H. The use of ABO-incompatible grafts in liver transplantation: a life- saving procedure in highly selected patients. Transplanta- tion. 1995;59:1124 –33.
   Google Scholar
• Fischer L, Sterneck M, Rogiers X. Liver transplanta- tion for acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:985–90.
   PubMed Web of Science ®Google Scholar
• Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhur y NR, Warkentin PI, Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338:1422 –6.
   Google Scholar
• Gazzard BG, Weston MJ, Murray-Lyon IM, Flax H, Record CO, Williams R, Portmann B, Langley PG, Dunlop EH, Mellon PJ, Ward MB. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974;1:1301–7.
   PubMed Web of Science ®Google Scholar
• Gerlach J, Kloppel K, Schauwecker HH, Tauber R, Muller C, Bucherl ES. Use of hepatocytes in adhesion and sus- pension cultures for liver support bioreactors. Int J Artif Organs. 1989;12:788 –92.
   Google Scholar
• Gerlach JC, Schnoy N, Encke J, Smith MD, Muller C, Neuhaus P. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment cap- illary systems: electron microscopy studies. Hepatology. 1995;22:546–52.
   PubMed Web of Science ®Google Scholar
• Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs. 1996;19:645 –54.
   Google Scholar
• Grompe M, Laconi E, Shafritz DA. Principles of therapeutic liver repopulation. Semin Liver Dis. 1999;19:7–14.
   PubMed Web of Science ®Google Scholar
• Grossman M, Raper SE, Wilson JM. Transplantation of genetically modifed autologous hepatocytes into non- human primates: feasibility and short-term toxicity. Hum Gene Ther. 1992;3:501–10.
   PubMed Web of Science ®Google Scholar
• Gubernatis G, Oldhafer K, Boker K, Bader A, Rodeck B, Schlitt HJ, Pichlmayr R. Is “terminal” liver damage re- versible? Value, practicality and future of bridging tech- niques for the liver [German]. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:380–8.
   PubMedGoogle Scholar
• Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulmi- nant hepatic failure: frst successful case report. World J Surg. 1991;15:660 –6.
   Google Scholar
• Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet. 1990;336:519 –23.
   Google Scholar
• Gunsalus JR, Brady DA, Coulter SM, Gray BM, Edge AS. Reduction of serum cholesterol in Watanabe rabbits by xenogenei c hepatocellular transplantation. Nat Med. 1997;3:48–53.
   PubMed Web of Science ®Google Scholar
• Gupta S, Bhargava KK, Novikoff PM. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis. 1999;19:15–26.
   PubMed Web of Science ®Google Scholar
• Gupta S, Vemuru RP, Lee CD, Yerneni PR, Aragona E, Burk RD. Hepatocytes exhibit superior transgene expression af- ter transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hep- atic gene therapy. Hum Gene Ther. 1994;5:959–67.
   PubMed Web of Science ®Google Scholar
• Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fe- tal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 1994;58:951 –2.
   Google Scholar
• Hamaguchi H, Yamaguchi Y, Goto M, Misumi M, Hisama N, Miyanari N, Mori K, Ogawa M. Hepatic biliary transport after hepatocyte transplantation in Eizai hyperbilirubine- mic rats. Hepatology. 1994;20:220 –4.
   Google Scholar
• Hanau C, Munoz SJ, Rubin R. Histopathological het- erogeneity in fulminant hepatic failure. Hepatology. 1995;21:345 –51.
   Google Scholar
• Hess F, Willemen A, Jerusalem C. Auxiliary liver trans- plantation in the rat, influence of the condition of the recipient’s liver on the fate of the graft. Eur Surg Res. 1977;9:270–9.
   PubMed Web of Science ®Google Scholar
• Ilan Y, Saito H, Thummala NR, Chowdhury NR. Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis. 1999;19:49–59.
   PubMed Web of Science ®Google Scholar
• Koebe HG, Schildberg FW. The artifcial liver–an interim report [German]. Wien Klin Wochenschr. 1998;110:551 – 63.
   Google Scholar
• Laconi E, Oren R, Mukhopadhya y DK, Hurston E, Laconi S, Pani P, Dabeva MD, Shafritz DA. Long-term, near- total liver replacement by transplantation of isolated hep- atocytes in rats treated with retrorsine. Am J Pathol. 1998;153:319 –29.
   Google Scholar
• Manns MP. New therapeutic aspects in fulminant hepatic failure. Chest. 1991;100:193S –196S.
   Google Scholar
• Markus PM, Becker H. Hepatocellular transplantation– from the beginning to clinical application [German]. Chirurg. 1999;70:162–8.
   PubMed Web of Science ®Google Scholar
• Matas AJ, Sutherland DE, Steffes MW, Mauer SM, Sowe A, Simmons RL, Najarian JS. Hepatocellular transplantation for metabolic defciencies: decrease of plasms bilirubin in Gunn rats. Science. 1976;192:892 –4.
   Google Scholar
• Mito M, Sawa M. Hepatocyte transplantation: past, present and future. Wiad Lek. 1997;50:416 –9.
   Google Scholar
• O’Grady JG, Gimson AE, O’Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfu- sion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988;94:1186 –92.
   Google Scholar
• Oldhafer KJ, Gubernatis G, Schlitt HJ, Rodeck B, Boker K, Pichlmayr R. Auxiliary partial orthotopic liver transplanta- tion for acute liver failure: the Hannover experience. Clin Transpl. 1994:181–7.
   Google Scholar
• Oren R, Dabeva MD, Karnezis AN, Petkov PM, Rosencrantz R, Sandhu JP, Moss SF, Wang S, Hurston E, La- coni E, Holt PR, Thung SN, Zhu L, Shafritz DA. Role of thy- roid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes. Hepatology. 1999;30:903 –13.
   Google Scholar
• Patience C, Takeuchi Y, Weiss RA. Zoonosis in xenotrans- plantation. Curr Opin Immunol. 1998;10:539 –42.
   Google Scholar
• Rajvanshi P, Fabrega A, Bhargava KK, Kerr A, Pollak R, Blanchard J, Palestro CJ, Gupta S. Rapid clearance of trans- planted hepatocytes from pulmonary capillaries in rats in- dicates a wide safety margin of liver repopulation and the potential of using surrogate albumin particles for safety analysis. J Hepatol. 1999;30:299 –310.
   Google Scholar
• Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S. Studies of liver repopulation using the dipeptidyl pepti- dase IV-defcient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatol- ogy. 1996;23:482 –96.
   Google Scholar
• Redeker AG, Yamahiro HS. Controlled trial of exchange- transfusion therapy in fulminant hepatitis. Lancet. 1973;6:3–6.
   Google Scholar
• Riordan SM, Williams R: Extracorporeal support and hep- atocyte transplantation in acute liver failure and cirrhosis. J Gastroenterol Hepatol. 1999;14:757 –70.
   Google Scholar
• Rozga J, Holzman MD, Ro MS, Griffn DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA. Development of a hybrid bioartifcial liver. Ann Surg. 1993;217:502 –11.
   Google Scholar
• Sandbichler P, Then P, Vogel W, Erhart R, Dietze O, Philadelphy H, Fridrich L, Klima G, Margreiter R. Hep- atocellular transplantation into the lung for temporary support of acute liver failure in the rat. Gastroenterology 1992;102:605 –9.
   Google Scholar
• Shaw BW Jr. Auxiliary liver transplantation for acute liver failure. Liver Transpl Surg. 1995;1:194–200.
   PubMedGoogle Scholar
• Silk DB, Trewby PN, Chase RA, Mellon PJ, Hanid MA, Davies M, Langley PG, Wheeler PG, Williams R. Treat- ment of fulminant hepatic failure by polyacrylonitrile- membrane haemodialysis. Lancet. 1977;2:1–3.
   PubMed Web of Science ®Google Scholar
• Sommer BG, Sutherland DE, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc. 1979;11:578–84.
   PubMed Web of Science ®Google Scholar
• Soyer T, Lempinen M, Walker JE, Supanwani d P, Eiseman B. Extracorporeal assist of anhepatic animals with liver slice perfusion. Am J Surg. 1973;126:20 –4.
   Google Scholar
• Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplanta- tion for the treatment of human disease. Semin Liver Dis. 1999;19:39–48.
   PubMed Web of Science ®Google Scholar
• Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63:559–69.
   PubMed Web of Science ®Google Scholar
• Sussman NL, Chong MG, Koussayer T, He DE, Shang TA, Whisennand HH, Kelly JH. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepa- tology. 1992;16:60–5.
   PubMed Web of Science ®Google Scholar
• Terpstra OT, Reuvers CB, Schalm SW. Auxiliary heterotopic liver transplantation. Transplantation. 1988;45:1003 –7.
   Google Scholar
• Terpstra OT, Schalm SW, Weimar W, Willemse PJ, Baumgartner D, Groenland TH, ten Kate FW, Porte RJ, de Rave S, Reuvers CB, et al. Auxiliary partial liver trans- plantation for end-stage chronic liver disease. N Engl J Med. 1988;319:1507 –11.
   Google Scholar
• van Hoek B, de Boer J, Boudjema K, Williams R, Corsmit O, Terpstra OT. Auxiliary versus orthotopic liver trans- plantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol. 1999;30:699–705.
   PubMedGoogle Scholar
• Van Thiel DH, Stauber R, Gavaler JS, Francavilla A. Hep- atic regeneration. Effects of age, sex hormone status, pro- lactin, and cyclosporine. Dig Dis Sci. 1991;36:1309 –12.
   Google Scholar